Silence Therapeutics reported $12K in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AstraZeneca USD -204M 3.48B Mar/2026
Autolus Therapeutics Ltd USD 24.57M 762K Mar/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Novartis USD 3.46B 83M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Silence Therapeutics USD 12K 52K Dec/2025